Electrical Impedance Tomography for Monitoring Lung Disease
Official title: The Use of Electrical Impedance Tomography (EIT) in Pulmonary Diseases
Run by University Hospital Olomouc · NCT07356076 · Data updated 2026-11-12
This test tries to see if a painless, noninvasive imaging method called electrical impedance tomography (EIT) can track how air is distributed in the lungs of adults with lung diseases and healthy volunteers and how those results match standard spirometry.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | University Hospital Olomouc Academic / other |
| Locations | 1 site (Olomouc) |
| Status | Recruiting |
| Started | November 1, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2028 |
| Registry record updated | January 27, 2026 |
| Trial ID | NCT07356076 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with COPD, asthma, pulmonary fibrosis, pneumonia, or residual post-COVID lung findings, as well as healthy volunteers (non-smokers or ex-smokers) who can attend testing, are the ideal candidates.
✕Probably not a fit
People under 18, pregnant individuals, those with severe cardiovascular disease, or those unable to give informed consent are excluded and would not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will use Electrical Impedance Tomography (EIT) to record real-time, spatial patterns of lung ventilation in adults with a range of lung diseases and in healthy volunteers. Participants will undergo noninvasive EIT recordings alongside standard seated spirometry when possible, and a subgroup who cannot perform spirometry will be included to examine EIT utility without forced breathing. Investigators will compare EIT images with spirometry measures and normal reference data to identify ventilation patterns associated with different lung conditions. The work is conducted at the Department of Pulmonary Diseases and Tuberculosis, University Hospital Olomouc.
Why it matters
Potential benefit: If successful, EIT could provide a painless bedside way to detect and monitor regional lung problems, especially for patients who cannot perform spirometry.
How similar studies have gone: Prior research and clinical use of EIT in critical care and ventilation monitoring have shown promise, but using EIT broadly for routine outpatient lung diagnosis remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years and older * Individuals diagnosed with any of the following lung diseases, as these are the primary focus of the study: Chronic obstructive pulmonary disease, Asthma, Pulmonary fibrosis, Pneumonia, Patients with a history of COVID-19 infection showing residual pulmonary findings. * Additionally, healthy subjects will be enrolled to obtain normal standard values (with normal physical examination and no respiratory symptoms, BMI 18-36 - cause EIT performance can be BMI dependent, Non-smokers or ex-smokers abstinent ≥12 months) * Ability to perform spirometry while seated, except for possible participants who are specifically part of a subgroup analysis where inability to perform spirometry is the condition which is studied. Signing of an informed consent that has been approved by the ethics committee Exclusion Criteria: * Patients under 18 years of age * Severe cardiovascular disease * Pregnancy * Inability to express consent * Acute respiratory infection: Except for those recovering from pneumonia or COVID-19 within the study focus, participants with current respiratory infections will be excluded to avoid confounding effects on lung function tests * Inability to perform spirometry
Where it's running
-
Department of Pulmonary Diseases and Tuberculosis, University hospital Olomouc
Olomouc, Czechia Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mosliciguat added to inhaled treprostinil for pulmonary hypertension from ILD
This trial tests whether adding inhaled mosliciguat to your inhaled treprostinil is safe and tolerable for people with pulmonary hypertension caused by interstitial lung disease.
-
Collecting lung sound recordings using Eko digital stethoscopes in clinic
This project will try to teach computer programs to recognize wheeze, crackles, rhonchi, stridor, rales, and cough from stethoscope recordings in adults with suspected or diagnosed lung conditions and in people with normal lungs.
-
Multi-omics prediction of graft problems after lung transplant
We will test whether repeated blood and lung-fluid multi-omics tests can spot early graft dysfunction in adults after lung transplantation.
-
Recording lung sounds with Eko digital stethoscopes in clinic
This project will test an AI that listens to lung sounds recorded with Eko digital stethoscopes to find abnormal sounds in people with or without lung disease.
-
Trop2- and EpCAM-targeted PET/CT to help distinguish non-small cell lung cancer
This project will test whether PET/CT scans that target Trop2 and EpCAM can show protein expression in tumors of people with suspected non-small cell lung cancer.
-
Early intervention strategies for lung cancer detection
This study is testing if using low-dose CT scans in community health centers can help find lung cancer earlier in people aged 40-75 who don't have a history of the disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.